Search Results - "Fiorica, James"

Breast Cancer Screening, Mammography, and Other Modalities by FIORICA, JAMES V

“…This article is an overview of the modalities available for breast cancer screening. The modalities discussed include digital mammography, digital breast…”
Get full text

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study by Fleming, Gini F, Sill, Michael W, Darcy, Kathleen M, McMeekin, D. Scott, Thigpen, J. Tate, Adler, Lisa M, Berek, Jonathan S, Chapman, Julia A, DiSilvestro, Paul A, Horowitz, Ira R, Fiorica, James V

“…Abstract Purpose This study evaluated efficacy of single-agent trastuzumab against advanced or recurrent HER2-positive endometrial carcinoma (EC), and explored…”
Get full text

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study by LONG, Harry J, BUNDY, Brian N, GRENDYS, Edward C, BENDA, Jo Ann, MCMEEKIN, D. Scott, SOROSKY, Joel, MILLER, David S, EATON, Lynne A, FIORICA, James V

“…On the basis of reported activity of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) or topotecan plus cisplatin in advanced cervix cancer, we…”
Get full text

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases by Pal, Tuya, Permuth‐Wey, Jenny, Betts, Judith A., Krischer, Jeffrey P., Fiorica, James, Arango, Hector, LaPolla, James, Hoffman, Mitchell, Martino, Martin A., Wakeley, Katie, Wilbanks, George, Nicosia, Santo, Cantor, Alan, Sutphen, Rebecca

“…BACKGROUND It is believed that BRCA1 and BRCA2 germline mutations account for the majority of hereditary ovarian carcinomas; however, to the authors'…”
Get full text

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study by Schilder, Russell J, Brady, William E, Lankes, Heather A, Fiorica, James V, Shahin, Mark S, Zhou, Xun C, Mannel, Robert S, Pathak, Harsh B, Hu, Wei, Alpaugh, R. Katherine, Sood, Anil K, Godwin, Andrew K

“…Abstract Objectives Preclinical data suggest an important role for the sarcoma proto-oncogene tyrosine kinase (SRC) in the oncogenesis of epithelial ovarian…”
Get full text

Activation and Overexpression of Centrosome Kinase BTAK/Aurora-A in Human Ovarian Cancer by GRITSKO, Tatiana M, COPPOLA, Domenico, PACIGA, June E, LIN YANG, MEI SUN, SHELLEY, Sue A, FIORICA, James V, NICOSIA, Santo V, CHENG, Jin Q

“…Previous studies have demonstrated amplification of the centrosome serine/threonine kinase BTAK/Aurora-A in 10–25% of ovarian cancers. However, alterations of…”
Get full text

Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651–Gynecologic Oncology Group 183 by HRICAK, Hedvig, GATSONIS, Constantine, IYER, Revathy, VITELLAS, Kenneth M, SNYDER, Bradley, LONG, Harry J, FIORICA, James V, MITCHELL, Donald G, CHI, Dennis S, AMENDOLA, Marco A, BRANDT, Kathy, SCHWARTZ, Lawrence H, KOELLIKER, Susan, SIEGELMAN, Evan S, BROWN, Jeffrey J, MCGHEE, Robert B

“…To compare magnetic resonance imaging (MRI) and computed tomography (CT) with each other and to International Federation of Gynecology and Obstetrics (FIGO)…”
Get full text

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study by Fiorica, James V, Brunetto, Virginia L, Hanjani, Parviz, Lentz, Samuel S, Mannel, Robert, Andersen, Willie

“…Objectives. To estimate the objective response rate and toxicity associated with alternating megestrol acetate (MA) and tamoxifen citrate (T) in women with…”
Get full text

Lysophospholipids Are Potential Biomarkers of Ovarian Cancer by SUTPHEN, Rebecca, YAN XU, GRIFFIN, David, BLANCO, Rafael W, CANTOR, Alan B, XIAO, Yi-Jin, KRISCHER, Jeffrey P, WILBANKS, George D, FIORICA, James, GRENDYS, Edward C, LAPOLLA, James P, ARANGO, Hector, HOFFMAN, Mitchell S, MARTINO, Martin, WAKELEY, Katie

“…Objective: To determine whether lysophosphatidic acid (LPA) and other lysophospholipids (LPL) are useful markers for diagnosis and/or prognosis of ovarian…”
Get full text

Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183 by AMENDOLA, Marco A, HRICAK, Hedvig, MITCHELL, Donald G, SNYDER, Bradley, CHI, Dennis S, LONG, Harry J, FIONCA, James V, GATSOMS, Constantine

“…To review the current utilization of diagnostic tests prescribed by the International Federation of Gynecology and Obstetrics (FIGO) clinical staging…”
Get full text

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study by Fiorica, James V, Blessing, John A, Puneky, Louis V, Secord, Angeles Alvarez, Hoffman, James S, Yamada, S. Diane, Buekers, Thomas E, Bell, Jeffrey, Schilder, Jeanne M

“…Abstract Purpose To estimate antitumor activity and toxicity of weekly topotecan hydrochloride in patients with persistent or recurrent cervical carcinoma who…”
Get full text

In vitro chemoresponse in metachronous pairs of ovarian cancers by Dalton, Heather J, Fiorica, James V, Edwards, Robert P, Benjamin, Ivor, Rocconi, Rodney P, Recio, Fernando O, Lovecchio, John L, Burrell, Matthew O, Shahin, Mark S, Grendys, Edward C, Wang, Dakun, Wang, Tianhua, Monk, Bradley J

“…An in vitro chemoresponse assay may aid effective therapy selection in epithelial ovarian cancer (EOC). This study explores changes in chemoresponse between…”
Get full text

Upper vaginectomy for the treatment of vaginal intraepithelial neoplasia by Indermaur, Megan D., Martino, Martin A., Fiorica, James V., Roberts, William S., Hoffman, Mitchel S.

“…The purpose of this study was to evaluate the use of upper vaginectomy for the treatment of vaginal intraepithelial neoplasia (VAIN). We conducted a…”
Get full text

The role of topotecan in the treatment of advanced cervical cancer by Fiorica, James V.

“…Improvements in the early detection of cervical cancer have markedly reduced associated mortality rates over the past few decades; however, in patients…”
Get full text

Subcutaneous management of vertical incisions with 3 or more centimeters of subcutaneous fat by Cardosi, Richard J., Drake, Janet, Holmes, Sherri, Tebes, Stephen J., Hoffman, Mitchel S., Fiorica, James V., Roberts, William S., Grendys, Edward C.

“…This study was undertaken to determine the most appropriate management of the subcutaneous tissue of midline vertical incisions with 3 cm or more of…”
Get full text

Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: Implications regarding surgical management by Hoffman, Mitchel S., Griffin, David, Tebes, Stephen, Cardosi, Richard J., Martino, Martin A., Fiorica, James V., Lockhart, Jorge L., Grendys, Edward C.

“…The purpose of this study was to 1) report on the distribution of bowel segments resected in a population of patients who underwent primary optimal…”
Get full text

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study by Long, Harry J., Monk, Bradley J., Huang, Helen Q., Grendys, Edward C., McMeekin, D. Scott, Sorosky, Joel, Miller, David S., Eaton, Lynne A., Fiorica, James V.

“…The Gynecologic Oncology Group (GOG) compared methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) with topotecan and cisplatin (TC) or cisplatin alone…”
Get full text

Update on the Treatment of Cervical and Uterine Carcinoma: Focus on Topotecan by Fiorica, James V.

“…Learning Objectives After completing this course, the reader will be able to: Identify the need for new chemotherapeutic agents in the treatment of advanced…”
Get full text

Bartholin's Gland Carcinoma: A 15-Year Experience by Cardosi, Richard J., Speights, Anthony, Fiorica, James V., Grendys, Edward C., Hakam, Ardeshir, Hoffman, Mitchel S.

“…Objective. Our objective was to review our experience with carcinoma of Bartholin's gland relative to treatment and oncologic outcome. Methods. Patient names…”
Get full text

Diagnosing pulmonary embolism: Experience with spiral CT pulmonary angiography in gynecologic oncology by Martino, Martin A., Williamson, Eva, Siegfried, Sylvia, Cardosi, Richard J., Cantor, Alan B., Hoffman, Mitchel S., Fiorica, James V.

“…To review our experience with the diagnosis and prognosis of pulmonary embolism (PE) in gynecologic oncology patients. Spiral CT pulmonary angiography (CTPA)…”
Get full text